We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laser Capture Microdissection Instrument Is Rapid and Precise

By HospiMedica staff writers
Posted on 09 Feb 2007
The open-architecture microdissection system is built upon an inverted research grade microscope and combines infrared (IR) laser-enabled laser capture microdissection (LCM) and ultraviolet (UV) laser cutting in a single modular instrument, offering scientists superior speed, precision, and flexibility.

The Arcturus laser capture instrument utilizes the Nikon TE2000U and is completely modular and fully upgradeable, allowing the system utility to expand as research requirements grow and microdissection technologies emerge.

The Arcturus instrument employs Molecular Devices', (Sunnyvale, CA, USA) LCM technology and, combined with the system's automated image archiving, enables scientists to maintain sample custody at all times, taking the guesswork out of microdissection. More...
Optional high-intensity halogen illumination enables phase contrast and differential interference contrast (DIC), making the system ideal for live-cell applications. The available microscope port also enables system modification for alternate applications, with potential add-ons, such as optical trap laser tweezers, for high-precision micromanipulation of microscopic particles, or an additional camera for high-resolution imaging. The intuitive software and ergonomic user interface have been designed to make microdissection simple and straightforward.

Varshal Dave, director of marketing for LCM and Microarray Systems at Molecular Devices, said, Arcturus is the first modular, upgradeable LCM instrument with a unique infrared capture and UV laser cutting in one system. This system offers scientists the broadest scientific applicability in the microdissection market, while maintaining the ease-of-use and performance our customers have come to expect. As with all of our previous LCM instrument offerings, the Arcturus system documents the entire microdissection process from start to finish, enabling the tracking of captured samples. Furthermore, the Arcturus offers scientists additional flexibility by allowing them to utilize any type of sample preparation slide type, which is not offered with other commercial instruments. We are extremely excited about the benefits the Arcturus will provide to our microdissection customers.

Molecular Devices is a supplier of high-performance bioanalytical measurement systems. Molecular Devices' systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics and proteomics. The company's solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology, and chemistry.





Related Links:
Molecular Devices

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.